A Rare Syndrome in Rapid Succession: A Case Report of Two Patients With Chorea‐Hyperglycemia‐Basal Ganglia (CHBG) Syndrome Within One Month
Case Reports in Neurological Medicine · 2026-01 · 2026 (1)
DOI: 10.1155/crnm/3607659 ↗Abstract
Chorea‐Hyperglycemia‐Basal Ganglia (CHBG) syndrome, also referred to as diabetic striatopathy, is a very rare and poorly understood cause of chorea and ballismus. Common features of CHBG syndrome include unilateral chorea or ballismus, hyperglycemia, and basal ganglia hyperintensity on neuroimaging. We present two cases of CHBG syndrome who were hospitalized at our community hospital within a 1‐month period, an occurrence that is exceedingly rare. The first case presented with subacute progressive right‐sided hemiballismus and the second case presented with acute monochorea of the left upper extremity. Both cases presented with uncontrolled Type II diabetes mellitus with HbA1c values ≥ 14%. Both cases experienced symptoms that persisted despite sleep, which is an atypical characteristic among those with CHBG syndrome. In both cases, the formal radiology reports were interpreted as normal. Retrospective review identified faint T1‐weighted hyperintensity of the left basal ganglia in Case 1. In Case 2, the consulting neurologist questioned the presence of a very subtle T1‐weighted hyperintensity of the right putamen; however, this finding was not described in the formal radiology report, could not be definitively attributed to CHBG syndrome, and its significance remains uncertain. Both cases had significant improvement in their symptoms with strict glycemic management, and both were prescribed adjunctive antichorea medications for additional symptom control. CHBG syndrome is important for physicians to know about and be able to recognize in order to arrive at a timely diagnosis and avoid unnecessary diagnostic testing.
EUVIMED